CD8(+) T-cell responses to adeno-associated virus capsid in humans
- PMID: 17369837
- DOI: 10.1038/nm1549
CD8(+) T-cell responses to adeno-associated virus capsid in humans
Abstract
Hepatic adeno-associated virus (AAV)-serotype 2 mediated gene transfer results in transgene product expression that is sustained in experimental animals but not in human subjects. We hypothesize that this is caused by rejection of transduced hepatocytes by AAV capsid-specific memory CD8(+) T cells reactivated by AAV vectors. Here we show that healthy subjects carry AAV capsid-specific CD8(+) T cells and that AAV-mediated gene transfer results in their expansion. No such expansion occurs in mice after AAV-mediated gene transfer. In addition, we show that AAV-2 induced human T cells proliferate upon exposure to alternate AAV serotypes, indicating that other serotypes are unlikely to evade capsid-specific immune responses.
Similar articles
-
Identification of mouse AAV capsid-specific CD8+ T cell epitopes.Mol Ther. 2005 Dec;12(6):1023-33. doi: 10.1016/j.ymthe.2005.09.009. Epub 2005 Nov 2. Mol Ther. 2005. PMID: 16263332
-
Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes.Mol Ther. 2007 Apr;15(4):792-800. doi: 10.1038/sj.mt.6300090. Epub 2007 Jan 23. Mol Ther. 2007. PMID: 17245353
-
Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid.Nat Med. 2006 Aug;12(8):967-71. doi: 10.1038/nm1445. Epub 2006 Jul 16. Nat Med. 2006. PMID: 16845388
-
Immune responses to AAV in clinical trials.Curr Gene Ther. 2007 Oct;7(5):316-24. doi: 10.2174/156652307782151425. Curr Gene Ther. 2007. PMID: 17979678 Review.
-
Immune responses to AAV in clinical trials.Curr Gene Ther. 2011 Aug;11(4):321-30. doi: 10.2174/156652311796150354. Curr Gene Ther. 2011. PMID: 21557723 Review.
Cited by
-
Immunogenicity and toxicity of AAV gene therapy.Front Immunol. 2022 Aug 12;13:975803. doi: 10.3389/fimmu.2022.975803. eCollection 2022. Front Immunol. 2022. PMID: 36032092 Free PMC article. Review.
-
An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression.FASEB J. 2013 Sep;27(9):3753-62. doi: 10.1096/fj.13-232090. Epub 2013 Jun 10. FASEB J. 2013. PMID: 23752206 Free PMC article.
-
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells.Blood. 2013 Mar 21;121(12):2224-33. doi: 10.1182/blood-2012-10-460733. Epub 2013 Jan 16. Blood. 2013. PMID: 23325831 Free PMC article.
-
Clinical development of gene therapy: results and lessons from recent successes.Mol Ther Methods Clin Dev. 2016 May 25;3:16034. doi: 10.1038/mtm.2016.34. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 27257611 Free PMC article. Review.
-
T Cell-Mediated Immune Responses to AAV and AAV Vectors.Front Immunol. 2021 Apr 13;12:666666. doi: 10.3389/fimmu.2021.666666. eCollection 2021. Front Immunol. 2021. PMID: 33927727 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials